Ovarian hormone effects on 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor mRNA expression in the ventral hippocampus and frontal cortex of female rats

被引:30
|
作者
Birzniece, V
Johansson, IM
Wang, MD
Bäckström, T
Olsson, T
机构
[1] Umea Univ Hosp, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden
[2] Umea Univ Hosp, Dept Clin Sci Obstet & Gynecol, SE-90185 Umea, Sweden
关键词
5-HT2A receptor; 5-HT2C receptor; in situ hybridization; estradiol; progesterone; hippocampus;
D O I
10.1016/S0304-3940(01)02570-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alterations in female gonadal hormones are associated with anxiety and mood changes. The aim of the present study was to determine influences of chronic gonadal hormone supplementation on 5-HT2A and 5-HT2C receptor mRNA levels in the ventral hippocampus and the frontal cerebral cortex. Ovariectomized adult female Sprague-Dawley rats (n = 37) received implantation of subcutaneous pellets containing different dosages of 17beta-estradiol alone or in combination with progesterone, or placebo pellets, for 2 weeks. Serotonin receptor mRNA levels were analyzed by in situ hybridization in the ventral hippocampus and 5-HT2A receptor mRNA also in the frontal cortex. Estradiol treatment in combination with low-dose progesterone increased 5-HT2A receptor mRNA by 43% in the CA2 region of the ventral hippocampus, while estradiol combined with high-dose progesterone increased the expression of this gene by 84% in ventral CA1. 5-HT2A mRNA expression in the frontal cortex was not influenced by hormone manipulation. 5-HT2C receptor gene expression was in the ventral hippocampus decreased in the CA2, ventral CA1 and the subiculum subregions by high-dose estradiol treatment (8-20% decreases). Effects on mood by gonadal hormones can be mediated, at least partly, through influences on 5-HT2A and 5-HT2C receptor expression. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 50 条
  • [1] Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation
    Berg, KA
    Stout, BD
    Maayani, S
    Clarke, WP
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (02): : 593 - 602
  • [2] 5-hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C):: Where structure meets function
    Roth, BL
    Willins, DL
    Kristiansen, K
    Kroeze, WK
    [J]. PHARMACOLOGY & THERAPEUTICS, 1998, 79 (03) : 231 - 257
  • [3] Gonadal hormones modulate 5-hydroxytryptamine2A receptors:: Emphasis on the rat frontal cortex
    Cyr, M
    Bossé, R
    Di Paolo, T
    [J]. NEUROSCIENCE, 1998, 83 (03) : 829 - 836
  • [4] 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics
    Weiner, DM
    Burstein, ES
    Nash, N
    Croston, GE
    Currier, EA
    Vanover, KE
    Harvey, SC
    Donohue, E
    Hansen, HC
    Andersson, CM
    Spalding, TA
    Gibson, DFC
    Krebs-Thomson, K
    Powell, SB
    Geyer, MA
    Hacksell, U
    Brann, MR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (01): : 268 - 276
  • [5] Antagonism of 5-hydroxytryptamine2A receptors attenuates the behavioral effects of cocaine in rats
    McMahon, LR
    Cunningham, KA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (01): : 357 - 363
  • [6] Antinociception with intrathecal α-Methyl-5-hydroxytryptamine, a 5-hydroxytryptamine2A/2C receptor agonist, in two rat models of sustained pain
    Sasaki, M
    Obata, H
    Saito, S
    Goto, F
    [J]. ANESTHESIA AND ANALGESIA, 2003, 96 (04): : 1072 - 1078
  • [7] Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine2A receptor
    Hanley, NRS
    Hensler, JG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02): : 468 - 477
  • [8] Proliferation and signaling in fibroblasts -: Role of 5-hydroxytryptamine2A receptor and transporter
    Welsh, DJ
    Harnett, M
    Maclean, M
    Peacock, AJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (03) : 252 - 259
  • [9] Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors
    Cryan, JF
    Lucki, I
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (03): : 1120 - 1126
  • [10] LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist:: a comparison with the antidepressant, nefazodone
    Pullar, IA
    Carney, SL
    Colvin, EM
    Lucaites, VL
    Nelson, DL
    Wedley, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (1-2) : 39 - 46